Climb Bio, Inc. CLYM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$52.79M+43.2% | -$59.85M+19.0% | -$50.75M+26.6% | -$46.76M+27.2% | -$92.98M-540% | ||
| $135K— | $97K— | $67K— | $38K— | —— | ||
| $7.64M+7.4% | $8.05M+44.9% | $8.67M+69.9% | $7.62M+169% | $7.11M+129% | ||
| -$53.3M-82.7% | -$54.36M-249% | -$44.24M-303% | -$39.66M— | -$29.18M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$177.59M-326% | ||
| -$16K-100% | -$21K-100% | $41K-100.0% | $2.31M-98.2% | $130.71M+15,188% | ||
| —— | —— | —— | -$200.46M-201% | -$76.01M-208% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Climb Bio, Inc. generate?
- Climb Bio, Inc. (CLYM) generated -$53.3M in operating cash flow over the trailing twelve months.
- What is Climb Bio, Inc.'s free cash flow?
- After $109.0K of capital expenditures, Climb Bio, Inc.'s free cash flow was -$41.0M over the trailing twelve months.
- Where does Climb Bio, Inc.'s cash flow data come from?
- Every line is extracted from Climb Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.